Phase 3 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with acute T-lymphocytic leukemia (a specific type of blood cancer), confirmed through bone marrow testing, with enough bone marrow sample available for laboratory analysis
- People who have never received any treatment for leukemia before
- People aged 18 or older (any gender)
- People whose general health and ability to carry out daily activities falls within a certain range, as measured by a standard medical scoring system called the ECOG scale (scores 0–2, meaning fully active to capable of limited self-care) (confirm with trial site)
- People who, or whose legal representative, are able to provide written consent before any study-specific procedures begin
Who may not be able to join:
- People whose leukemia is classified as a different type of leukemia under standard medical guidelines
- People who have previously had any chemotherapy or other systemic or local cancer treatment
- People who have previously had a stem cell transplant
- People who have or have had another type of cancer in addition to leukemia
- People with uncontrolled heart, blood vessel, or brain conditions, severe bleeding disorders, or serious uncontrolled infections
- People with a known history of allergic reactions to any of the medications used in this trial
- People whose heart pumping function (left ventricular ejection fraction) is at or below 50%
- People with certain abnormal blood test results at the time of screening, specifically relating to liver function or kidney function, unless those results are caused by the leukemia itself (confirm specific values with trial site)
- People with other ongoing medical conditions that the research team believes would affect safe participation in the study
- People with psychiatric conditions or any other reason that may make it difficult to follow the study requirements fully
- Women who are pregnant or breastfeeding
- People who are HIV-positive
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Qifa Liu, Nanfang Hospital, Southern Medical University
Phone: 02061641611
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.